27.4.2012 15:08:00 | Author/Source www.seenews.com
Bulgarian pharmaceuticals producer Bulgarian Rose-Sevtopolis [BUL:4BJ] said on Friday its non-consolidated net profit rose to 918,000 levs ($621,866/469,365 euro) in the first quarter of 2012 from 109,000 levs a year earlier.
The company’s non-consolidated revenue increased by 58% on the year to 5.3 million levs, Bulgarian Rose-Sevtopolis said in a bourse filing.
|